Williams Gary M, Iatropoulos Michael J
New York Medical College, Department of Pathology, Valhalla, New York 10595, USA.
Toxicol Pathol. 2002 Jan-Feb;30(1):41-53. doi: 10.1080/01926230252824699.
Exposure of experimental animals to biologically effective levels of chemicals, either endogenous or exogenous, the latter of either synthetic or natural origin, elicits a response(s) that reflects the diverse ways in which the various units of organization of an organism deal with chemical perturbation. For some chemicals, an initial response constitutes an adaptive effect that maintains homeostasis. Disruption of this equilibrium at any level of organization leads to an adverse effect, or toxicity. The livers of laboratory animals and humans, like other organs, undergo programmed phases of growth and development, characterized by proliferation followed by differentiation. With organ maturity, the process of differentiation leads to the commitment of differentiated cells to constitutive functions that maintain homeostasis and to specialized functions that serve organismal needs. In the mature livers of all species, proliferation of all cell types subsides to a low level, Thus, the mature liver consists of 2 types of cells: intermediate cells, the hepatocytes, which replicate infrequently, but can respond to signals for replication, and replicating cells, the stem cells, endothelial, Kupffer, and stellate cells (Ito or pericytes), bile duct epithelium, and granular lymphocytes (pit cells). Quantifiable alterations or effects at the molecular level underlie alterations at the organelle level, which in turn lead to alterations at the cellular level, which can ultimately be manifested as a change in the whole organism. Alterations can be quantal (binary), either all or none, as with cell replication, cell necrosis or apoptosis, and cell differentiation, which take place at the cellular level. They can also be graded or continuous (nonbinary), as with enzyme induction, organelle hypertrophy, and extracellular matrix elaboration, occurring either at the intra- or extra (supra) cellular level. Any quantifiable change induced in the function or structure of a cell or tissue constitutes a response or effect. Each of the several types of cell in the liver responds to a given stimulus according to its localization and function. Generally, renewing cells are more vulnerable to chemical injury than intermediate cells, which are largely quiescent. Hepatic adaptive responses usually involve actions of the chemical on cellular regulatory pathways, often receptor mediated, leading to changes in gene expression and ultimately alteration of the metabolome. The response is directed toward maintaining homeostasis through modulation of various cellular and extracellular functions. At all levels of organization, adaptive responses are beneficial in that they enhance the capacity of all units to respond to chemical induced stress, are reversible and preserve viability. Such adaptation at subtoxic exposures is also referred to as hormesis. In contrast, adverse or toxic effects in the liver often involve chemical reaction with cellular macromolecules and produce disruption of homeostasis. Such effects diminish the capacity for response, can be nonreversible at all levels of organization, and can compromise viability. An exposure that elicits an adaptive response can produce toxicity with longer or higher exposures (ie, above a threshold) and the mechanism of action changes with the effective dose. A variety of hepatic adaptive and toxic effects has been identified. Examples of adaptive effects are provided by phenobarbital and ciprofibrate, whereas p-dichlorobenzene and 2-acetylaminofluorene illustrate different toxic effects. The effects of chemicals in the liver are, in general, similar between experimental animals and humans, although exceptions exist. Thus, identification and monitoring of both types of effect are integral in the safety assessment of chemical exposures.
将实验动物暴露于生物有效水平的化学物质中,这些化学物质无论是内源性还是外源性的,后者无论是合成的还是天然来源的,都会引发一种反应,该反应反映了生物体组织的各个单位应对化学扰动的多种方式。对于某些化学物质,初始反应构成维持体内平衡的适应性效应。在任何组织水平上这种平衡的破坏都会导致不良反应或毒性。实验动物和人类的肝脏与其他器官一样,经历程序化的生长和发育阶段,其特征是先增殖后分化。随着器官成熟,分化过程导致分化细胞承担维持体内平衡的组成性功能以及满足机体需求的特殊功能。在所有物种的成熟肝脏中,所有细胞类型的增殖都降至低水平。因此,成熟肝脏由两种类型的细胞组成:中间细胞,即肝细胞,其很少复制,但能对复制信号作出反应;以及复制细胞,即干细胞、内皮细胞、库普弗细胞、星状细胞(伊托细胞或周细胞)、胆管上皮细胞和颗粒淋巴细胞(pit细胞)。分子水平上可量化的改变或效应是细胞器水平改变的基础,而细胞器水平的改变又会导致细胞水平的改变,最终可能表现为整个生物体的变化。改变可以是量子化的(二元的),即全有或全无,如细胞复制、细胞坏死或凋亡以及细胞分化,这些发生在细胞水平。它们也可以是分级的或连续的(非二元的),如酶诱导、细胞器肥大和细胞外基质形成,发生在细胞内或细胞外(超细胞)水平。在细胞或组织的功能或结构中诱导的任何可量化变化都构成一种反应或效应。肝脏中的几种细胞类型中的每一种都会根据其定位和功能对给定刺激作出反应。一般来说,更新细胞比主要处于静止状态的中间细胞更容易受到化学损伤。肝脏适应性反应通常涉及化学物质对细胞调节途径的作用,通常是受体介导的,导致基因表达变化并最终改变代谢组。该反应旨在通过调节各种细胞和细胞外功能来维持体内平衡。在所有组织水平上,适应性反应都是有益的,因为它们增强了所有单位应对化学诱导应激的能力,是可逆的并保持活力。在亚毒性暴露下的这种适应也被称为兴奋效应。相比之下,肝脏中的不良或毒性效应通常涉及与细胞大分子的化学反应并导致体内平衡破坏。这种效应会降低反应能力,在所有组织水平上可能是不可逆的,并可能损害活力。引发适应性反应的暴露在更长时间或更高剂量(即高于阈值)时可能产生毒性,并且作用机制会随着有效剂量而改变。已经确定了多种肝脏适应性和毒性效应。苯巴比妥和环丙贝特提供了适应性效应的例子,而对二氯苯和2-乙酰氨基芴则说明了不同的毒性效应。一般来说,实验动物和人类肝脏中化学物质的效应相似,尽管存在例外情况。因此,识别和监测这两种效应对于化学暴露的安全性评估至关重要。